Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses CRB-701 Data and Insights in Head and Neck Cancer Panel Transcript

Group 1 - The event was well-attended, indicating strong interest in the company's data and discussions, particularly regarding head and neck research [2] - The organization of the event was acknowledged, highlighting the efforts of LifeSci and the team involved in the webcast and recording [2] - The CEO of Corbus, Yuval Cohen, introduced the panel and expressed gratitude for the audience's presence [3]